StockWatch
·
Pharmaceuticals
Quarterly Result27 May 2026, 06:52 pm

Supriya Lifescience: FY26 Audited Results; ₹1 Dividend

AI Summary

Supriya Lifescience Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results and recommended a final dividend of ₹1.00 per equity share (50% on the face value of ₹2 each), subject to shareholder approval at the upcoming Annual General Meeting. The auditor's report indicated an unmodified opinion on the standalone financial results.

Key Highlights

  • Supriya Lifescience announced audited financial results for FY26.
  • Board recommends a final dividend of ₹1 per share (50%).
  • Auditor's report expresses an unmodified opinion on financial results.
  • AGM details will be intimated separately as per regulatory directives.